Novel device-delivery company emerges from stealth mode after receiving $15 million Series B from GSK's VC arm
May 17, 2011 | Analyst Insight
SpringLeaf Therapeutics, a Boston-based device-delivery company, emerged from stealth mode last week with the announcement of a $15 million Series B financing round led by the corporate venture capital arm of...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.